FdaApplication
ANDA 212278
Identifiers
- fda_app_no: ANDA212278
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT III |
| application_type | ANDA |
| approval_date | 2022-02-02 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE;ORAL |
| ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE;ORAL |
| ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE;ORAL |
3 products